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A method is described in which anti-2-acetylaminofluorene immunoglobulins may be detected using a 
simple and sensitive screening procedure. The method is based on immunoglobulin binding of an 1251 
derivatized 2-aminofluorene radiotracer. Tracer binding is not isotype specific, and thus the method is 
useful for the detection of either IgG or IgA. Competitive binding experiments with the radiotracer were 
used to determine the specificity of immunoglobulin response by measurement of cross-reactivity with 
related ligands. This method allows quantitation of the immune response to the carcinogen in serum and 
other biological fluids (i.e., intestinal secretions). 
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2-(4-hydroxyphenylacetamido)fluorene; PT, Tween-supple- 
mented phosphate-buffered saline; SAF, N-2-fluorenylsuc- 
cinamic acid; TLC, thin layer chromatography; UV, ultra- 
violet. 
Introduction 
2-Acetylaminofluorene (2-AAF) is a well- 
studied model compound for the investigation of 
arylamine/arylacetamide carcinogenesis in several 
animal species. Upon absorption, the parent com- 
pound becomes a substrate for a variety of meta- 
boric enzymes, some of which detoxify the com- 
pound, while others produce reactive chemical 
intermediates substantially more toxic to the 
organism than the parent compound (Miller et al., 
1960; Miller and Miller, 1964). N-hydroxylation 
of 2-AAF to the arylhydroxamic acid (Miller et 
al., 1960; Frederick et al., 1982) and subsequent 
phase 2 conjugation via sulfation (DeBaun et al., 
1968; Meerman et al., 1981; Lai et al., 1985, 
1987), glucuronidation (Sakai et al., 1978), N,O- 
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acyltransfer (Weeks et al., 1978), or O-acetylation 
(Flamang and Kadlubar, 1986) can result in the 
formation of electrophilic intermediates capable of 
damaging cellular macromolecules. The formation 
of DNA adducts which result from the reaction of 
electrophilic 2-AAF metabolites with nucleophilic 
centers in the DNA helix, have been postulated to 
serve as a committed initiation step in the neo- 
plastic transformation of cells (Garner et al., 1984; 
Miller and Miller, 1981). 
Several investigators have attempted to prevent 
the sequence of metabolic events leading to DNA 
damage by immobilizing the parent carcinogen 
immunologically prior to activation and toxicity 
(Creech and Franks, 1937; Franks and Creech, 
1939; Peck and Peck, 1971; Moolton and Cap- 
parell, 1978; Moolton et al., 1978; Tompa et al., 
1979; Moolton et al., 1981). Using parenteral im- 
munization, these studies have demonstrated the 
ability to produce a systemic humoral immunity 
(IgG) to several carcinogens. Although some stud- 
ies have shown that the presence of this humoral 
immunity correlated with an inhibition of chem- 
ically induced neoplasia, others have shown an 
increase in tumorigenesis following immunization 
(Creech and Franks, 1937; Curtis et al., 1978). 
Moolton et al. (1978) suggested that the develop- 
ment of a mucosal immunity (IgA) to 7,12-di- 
methylbenz(a)athracene (DMBA) and related PAH 
carcinogens could facilitate excretion of the 
carcinogen by preventing absorption into the body. 
Mice immunized with an intraperitoneal, followed 
by an intragastric dose of a fluorinated derivative 
of DMBA-BSA conjugate showed increased levels 
of [3H]benzo(a)pyrene binding in the ~,-globulin 
fraction of fecal extracts following ingestion of the 
radiolabelled carcinogen. However, no direct de- 
termination of the presence of IgA-anti-PAH was 
made in these studies. 
Recent studies in our laboratory aimed at 
stimulating a mucosal immune response against 
2-AAF (Keren et al., 1987) have created a need 
for a simple, sensitive method for screening large 
numbers of biological fluids for anti-AAF im- 
munoglobulins. In the present report we describe 
the synthesis of a radiotracer bearing the amino- 
fluorene hapten covalently coupled to p-hydroxy- 
phenylacetic acid, which is subsequently iodinated 
with Na125I. Binding of this radiotracer serves as 
the basis of a sensitive immunoassay for the detec- 
tion of anti-AAF immunoglobulins. Cross-reactiv- 
ity studies using this radiotracer have provided 
information on the specificity of the immuno- 
globulin response to AAF-protein conjugates. 
Competitive microELISA experiments have con- 
firmed the presence of IgG anti-AAF immuno- 
globulins in sera from immunized rats and rabbits 
testing positive by the 1251 binding assay de- 
scribed. Similarly, IgA-anti-AAF immunoglobu- 
lins have been detected in rabbit intestinal secre- 
tions following immunization with AAF-carrier 
protein conjugates using this method (Keren et al., 
1987). 
Materials and methods 
Succinic anhydride, 2-acetylaminofluorene (2- 
AAF), 1-ethyl-3-(3-dimethylaminopropyl)carbodi- 
imide-HC1 (EDAC), bovine serum albumin, 
ovalbumin, thyroglobulin, p-nitrophenyl phos- 
phate, and fluorene were obtained from Sigma 
Chemical Co. (St. Louis, MO). Anthracene, 2- 
aminofluorene (2-AF), 2-nitrofluorene, 9-amino- 
fluorene-HC1, carbazole, biphenyl, 1-aminofluo- 
rene, 2-aminoanthracene, 3-aminofluoranthene, 
and 3-amino-9-ethylcarbazole were obtained from 
Aldrich Chemical Co. (Milwaukee, WI). New Zea- 
land White rabbits were purchased from Lang- 
shaw, Sprague-Dawley rats were purchased from 
Charles River, ELISA microtiter plates were ob- 
tained from Dynatech, Tween 20 was purchased 
from Baker Chemical Co., and goat anti-rat IgG 
(GARTG) was purchased from Cappel. All other 
buffers, solvents and reagents were analytical grade 
or better. 
Melting points were determined with a Thomas 
Hoover capillary melting point apparatus and are 
uncorrected. The Ig  spectra were recorded on a 
Perkin Elmer 281 spectrophotometer and values 
are expressed in cm 1. The 1H nmr spectra were 
obtained on a Bruker WP270SY (270 MHz) spec- 
trophotometer. The chemical shift values are re- 
ported in parts per million on the 8 scale with 
tetramethylsilane as the internal reference. The 
microanalyses were performed by M-H-W 
Laboratories, Phoenix, AZ. The thin layer chro- 
matography (TLC) was performed on silica gel-GF 
(Analtech) plates. The detection of compounds on 
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Fig. 1. Synthesis o f  the 1251-labelled radJotracer. Each num- 
bered compound was isolated, purified and analyzed as de- 
scribed in the materials and methods section. Compounds [4] 
and [5] were isolated by reverse phase HPLC following radio- 
iodination. 
TLC was made using UV light. The evaporation 
of solvents was carried out under reduced pressure 
with a rotary evaporator using a water aspirator at 
the temperature noted. 
Synthesis of the 1251 radiolabel 
N-2-(4-acetoxyphenylacetamido)fluorene [2]. 
The synthetic method used to prepared the a25I 
radiolabel is summarized in Fig. 1. The synthesis 
of the p-hydroxyphenylacetic anhydride [1] was 
accomplished using the method of Nordblom et 
al. (1981) * 
2-Aminofluorene (1.2 g, 6.62 mmol) was dis- 
solved in dry pyridine (100 ml). p-Acetoxyphenyl- 
acetic anhydride (3.85 g, 10.4 mmol) was then 
added and the mixture was heated at reflux for 1 
* The yield of anhydride can be greatly increased by omission 
of the NaHCO 3 wash step described. 
h. When complete, the mixture was acidified with 
1 N HC1 and extracted with methylene chloride 
(4 × 200 ml). The combined organic layer was 
washed successively with 100 ml portions of H2 O, 
1 M NaHCO 3, H20, 1 N HC1 and H20. The 
methylene chloride was dried over MgSO 4, filtered, 
and the solvent removed in vacuo. The resulting 
residue was dissolved in a minimum quantity of 
hot toluene, filtered through a Celite/decolorizing 
charcoal filter cake and allowed to crystallize. 
Collection of the solid yielded 0.84 g of N-2-(4- 
acetoxyphenylacetamido)fluorene ([2], 35% yield, 
MP = 189-192°C with decomposition). IR (KBr 
pellet) Vm~: 3305, 1755, 1660, 1590, 1510 cm -1. 
1H NMR (DMSO-d6): 2.24 (s,3H,CH3); 3.66 (s, 
2H,CH2); 3.87 (s,2H,CH2); 7.06-7.92 (m, l lH,  
aromatic H); 10.25 (s,IH,NH, exchangeable with 
D20 ). Calculated analysis for C23H19NO3:  C,  
77.28; N, 3.92; H, 5.37. Found: C, 77.11; N, 3.93; 
H, 5.40. 
N-2-(4-hydroxyphenylacetamido)fluorene [3]. 
N-2-(4-Acetoxyphenylacetamido)fluorene [2] (200 
mg, 0.56 mmol) was dissolved in dry methanol (50 
ml), and sodium methoxide (10 /zg) was added. 
The solution was heated to 40 °C and stirred for 4 
h. After allowing the mixture to cool to room 
temperature, the methanol was removed in vacuo 
and the remaining solid was suspended in H20 
(500 nal). The pH was adjusted to 2 with 1 N HC1. 
The aqueous suspension was extracted with meth- 
ylene chloride (4 × 200 ml). The combined organic 
extract was washed twice with H20 and dried over 
MgSO 4. The mixture was filtered and the solvent 
was evaporated in vacuo. The resulting solid was 
recrystallized from hot toluene to yield 100 mg of 
N-2-(4-hydroxyphenylacetamido)f luorene [3], 
(pHP-AAF, 57% yield, MP---207-210 °C with 
decomposition). IR (KBr pellet) Vma x, 3305, 1675, 
1520 cm -1. aH NMR (DMSO-d6): 3.51 (s,2H, 
CH2); 3.87 (s,2H,CH2); 6.68-7.94 (m, l lH ,  
aromatic H); 9.24 (s,IH,OH, exchangeable with 
D20); 10.13 (s,IH,NH, exchangeable with D20 ). 
Calculated analysis for C21H17NO2: C, 79.97; N, 
4.44; H, 5.44. Found: C, 79.89; N, 4.49; H, 5.69). 
Radioiodination of pHP-AAF [4],[5] 
N-2-(4-hydroxyphenylacetamido) fluorene [3] 
(10 mg, 0.03 mmol) was dissolved in methanol (10 
ml). To 2.0/~1 (6.3 nmol) of this solution in a 0.5 
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Fig. 2. HPLC elution of the 125I-pHP-AAF radiotracer. 
(D m) indicate the measured radioactivity contained in 
each fraction recovered from the HPLC column. (Lx A) 
indicates the gradient elution in % buffer B. Buffer A: 0.05 M 
potassium formate, pH 4.0. Buffer B: HPLC grade acetonitrile. 
The flow rate of elution was 1.0 ml/min. Fractions of 1 ml 
were collected and counted on an Eberline Miniscaler (MS-2), 
with an external geometry permitting 0.0022% of the total 
activity to be counted. 
dram vial, fitted with a multi-dose septum, was 
added 0.5 M potassium phosphate buffer, pH 7.4 
(buffer A, 40 #1), followed by aqueous Na125I (4.0 
mCi, dissolved in 9 ffl buffer A). The iodination 
was initiated with the addition of chloramine-T 
(30 Fg dissolved in 10 ffl of buffer A). The reac- 
tion was shaken for 2 min and quenched with 
sodium metabisulfite (30 #g, dissolved in 10 F1 
buffer A). The reaction mixture (containing com- 
pound [4] and [5], Fig. 1) was injected onto an 
Altech RPA 600 reverse phase C-18 HPLC col- 
umn and eluted initially with an isocratic 0.05 M 
potassium formate buffer (pH 4.0)/acetonitrile 
(80 : 20, v /v )  solvent system. A linear gradient was 
established from 5 to 80 min, with a final solvent 
mix of 40:60  formate buffer/acetonitrile. The 
remainder of the elution was performed isocrati- 
cally at the final solvent mixture ratios (Fig. 2). 
The solvent flow rate was held constant at 1 
ml /min  throughout the elution, and 2 ml fractions 
were collected for the first 30 min of the elution, 
followed by 1 ml fractions for the remainder of 
the elution. The radioactivity in each fraction was 
counted using an Eberline Mini-Scaler (MS-2) 
fitted with a 6 in tube such that the external 
geometry would only allow a small portion of the 
radioactivity to be registered (0.0022%), permit- 
ting identification of the active fractions without 
dilution. 
The specific radioactivity of the monoiodinated 
tracer was determined using the method of Morris 
(1976), which compares the amount of bound vs. 
free radiolabel in parallel incubations with either 
doubling dilutions of iodinated tracer ( 'hot'), or 
doubling dilutions of the 'cold' carrier molecule 
(the pHP-AAF), each in the presence of a small 
but constant quantity of radiotracer and antibody. 
For the radiolabelled self-displacement curve, ap- 
proximately doubling dilutions of isotope (pre- 
sumed to be the monoiodinated radiotracer) were 
dispensed ranging from 5000 to 570000 cpm. A 
constant quantity of radiolabel was added to each 
tube (11 000 cpm), and the self-displacement com- 
petition was initiated with the addition of 100 /~1 
of a 1 : 50 000 dilution of AF-60 rabbit anti-serum. 
The cold self-displacement curve was set-up in a 
similar fashion, only cold carrier compound (pHP- 
AAF) was added in a masses ranging from 10 
pmol to 1000 pmol. An identical mass of radioiso- 
tope was added to these tubes as in the 'hot '  
displacement samples above (11000 cpm), as well 
as the addition of the antiserum. Both sets of 
samples were allowed to equilibrate for 2 h at 
room temperature, followed by the separation of 
bound counts from free with the addition of 1.0 
ml dextran coated charcoal (kept at 4°C). The 
tubes were immediately centrifuged at 2400 rpm 
for 5 rain. The clear supernatants (containing anti- 
body bound counts) were transferred to clean 
tubes and counted in the Hydrogamma-16 gamma 
counter. The ratios of bound versus free counts 
were calculated for both sets of samples, and the 
amount of cold mass required to displace a known 
quantity of iodinated label was obtained. The 
specific activity of the radiotracer was determined 
graphically as described by Morris (1976). 
N-2-Fluorenylsuccinamic acid (SAF) 
2-Aminofluorene (5.0 g, 28 mmol) was dis- 
solved in dry pyridine (150 ml) under a nitrogen 
atmosphere. Succinic anhydride (7.5 g, 75 mmol) 
was added slowly with gentle stirring. The reac- 
tion was allowed to stand in the dark at room 
temperature with stirring for 14 h. The pyridine 
was removed in vacuo using a roto-evaporator and 
a dry ice trap. The resulting solid was recrystal- 
lized from absolute ethanol to yield 4.52 g of tan 
needles (57% yield, M P = 2 2 5 - 2 2 7 ° C  with de- 
composition). IR (KBr pellet) Vm~x, 3305, 1695, 
1650, 1590, 1510, 1420 cm -a. 1H N M R  (DMSO- 
d6): 3.26 (s,2H,CH2); 3.82 (s,4H,CH2-CH2); 
7.16-7.85 (m,7H,aromatic H); 9.97 (s,IH,COOH, 
exchangeable with D20); 12.06 (s,IN,NH, ex- 
changeable with D20 ). Analysis calculated for 
Ca7H]sNO3: C, 72.58; N, 4.98; H, 5.39. Found: C, 
72.44; N, 5.07; H, 5.50. 
Optimization of conjugation conditions 
Fig. 3 illustrates the conditions of the conjuga- 
tion reaction used to couple SAF to a variety of 
carrier proteins. 1-Ethyl-3-(3-dimethylaminopro- 
pyl)carbodiimide-HC1 (EDAC, 45 mg, 0.23 mmol) 
was dissolved in 1 ml of 0.05 M 2-(N- 
morpholino)ethanesulfonic acid (MES) buffer, pH 
4.75. This solution was added dropwise with stir- 
ring to a solution of 66 mg (0.23 mmol) SAF 
dissolved in 9 ml of dimethylformamide (DMF) 
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and allowed to stand for 1 h at room temperature 
with stirring. The cartier protein was dissolved in 
0.05 M cyclohexylaminoethane sulfonic acid buffer 
(CHES), pH 9.5 (0.42 #mol carrier protein dis- 
solved in 42 ml CHES buffer). The SAF solution 
was then added dropwise to the carrier protein 
solution with gentle stirring and allowed to stand 
for 14 h. The solution was transferred to dialysis 
tubing and dialyzed against 4-5 one liter changes 
of phosphate-buffered saline (PBS) until the ab- 
sorbance of the dialysate attained an absorbance 
less than 0.010 at 280 nm. The retentate (with the 
exception of thyroglobulin conjugates) was filtered 
through a 0.45 /~m filter and stored in 1.5 ml 
aliquots at - 20 o C. 
The degree of SAF substitution per mole of 
carrier protein was estimated in the following 
manner. The protein concentration of the con- 
jugated solution was determined by Coomassie 
blue dye binding assay (Bradford, 1976) and the 
absorbance of the conjugate solution was mea- 
sured at 280 nm. The absorbance of the carrier 
protein alone at a comparable concentration was 
estimated from a standard curve and subtracted 
from the latter value. The molar extinction coeffi- 
cient of SAF at 280 nm was determined to be 
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Fig. 3. Chemical coupling of SAF to carrier proteins. The conditions of the coupling reaction shown were cnUcal to achieve a high 
level of substitution. Details are provided in the materials and methods section. 
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20056 M-1 cm-a  by serial PBS dilutions at neu- 
tral pH from a 1 m g / m l  stock solution of SAF in 
dimethylformamide. The residual absorbance after 
subtraction of the protein absorbance was pre- 
sumably due to SAF and was converted to molar 
equivalents. The molar ratio of SAF to protein 
estimated by this method routinely fell in the 
range of 20-30 for albumin carrier proteins. 
Immunization and antibody response 
Four rabbits were given multiple-site in- 
tramuscular injections containing a total of 
200-400/~g SAF-carrier protein conjugate in 1 -2  
ml 50 : 50 complete Freund's adjuvant (CFA, PBS, 
v /v ) .  SAF-carrier protein conjugate (100 /~g in 
1.0-1.8 ml 50:50 complete Freund's adjuvant) 
were given to three rats, sub-cutaneously over the 
hips. Similar booster immunizations were given 16 
days later. Blood samples were collected weekly 
and tested for the capacity to bind the radiotracer 
in serial dilutions. Certain animals were given a 
second boost with the original conjugate, while 
others received SAF attached to a different carrier 
protein. 
The specificity of the antibody was determined 
by equilibrium competition experiments involving 
related chemical compounds. Each competing 
ligand was incubated in the presence of constant 
quantities of iodinated tracer (50000 cpm) and 
antibody (AF-60 antiserum, 1 :100000 dilution). 
Increasing amounts of each competing ligand were 
added to determine the mass at which 50% inhibi- 
tion of the radiolabel binding occurred (I50). The 
percent cross-reactivity was calculated relative to 
the I50 of the non-iodinated tracer (pHP-AAF).  
Competitive microELISA 
Competitive microELISA studies were per- 
formed in parallel with the IBA as an independent 
confirmation of the ability to detect anti-AAF 
immunoglobulins. Microtiter wells were coated 
overnight with 100 /~1 of 20 /~g/ml SAF-protein 
conjugates at 4 ° C  dissolved in 0.05 M bi- 
carbonate buffer, 1 mM MgC12, p H  9.6. Test 
antiserum was run in wells coated with a SAF- 
protein conjugate containing an unrelated carrier 
protein to reduce non-hapten-specific protein 
binding. Carrier protein control wells were run in 
parallel experiments and subtracted as a back- 
ground value from the total binding value. Anti- 
sera dilutions ranged f rom 1 : 50 to 1 : 200 for rat 
antisera and were 1 :20  for rabbit antisera with 
the exception of rabbit  AF-60 which was diluted 
1 : 2 0 0 0 0 .  For inhibition studies, increasing 
amounts of free 2-AAF were pre-incubated with 
the antisera for 1 h prior to its addition to the 
conjugate-containing well. The 2-AAF was diluted 
from a stock solution of 1 m g / m l  in DMF. The 
1000 ng 2-AAF competit ion values were per- 
formed at 1% DMF. All other experimental tubes 
were adjusted to contain 0.1% D M F  in PBS (v/v).  
The antigen-antibody binding was not effected at 
D M F  concentrations of 1% or less (data not 
shown). These mixtures were then added to the 
microtiter wells and incubated at room tempera- 
ture for 4 h. The plates were then washed with 
several volumes of PBS containing 0.05% Tween 
20 (PT), followed by the addition of alkaline phos- 
phatase-conjugated sheep anti-rabbit IgG (100/~1, 
isotype specific, affinity column purified using 
methods previously described) (Keren, 1979) to 
each well. For the rat antiserum studies, alkaline 
phosphatase-conjugated goat anti-rat IgG was 
used. After an overnight incubation, the wells 
were washed with PT, blotted dry, and the sub- 
strate reaction was carried out with the addition of 
100 #1 of p-nitrophenyl phosphate (1 m g / m l  stock 
solution) dissolved in substrate buffer (0.05 M 
N a 2 C O 3 / N a H C O  3, 1.0 mM, MgC12, pH 9.8). The 
absorbance of each well was measured at 12.5, 25, 
50 and 100 min on a Titertek microELISA reader 
using the 405 nm filter. If  the 100 min reading 
exceeded the linearity of the instrument (Abs. 
> 2.0), the 100 min measurement was extrapo- 
lated from the next earliest reading. Percent in- 
hibition was calculated from the mean of two 
wells containing 0-1000 ng 2-AAF based on simi- 
lar wells containing no 2-AAF. 
Results 
The reaction mixture produced from radio- 
iodination of the pHP-AAF tracer molecule was 
applied to a C-18 reverse-phase HPLC column as 
described in the materials and methods section. 
The elution profile shown in Fig. 2 contained 
three major peaks. Peak A contained 83% of the 
total radioactivity applied to the column as free 
1251 anion. Peak B, which eluted in fractions 39-41 
(69-71 min time of elution) contained the mono- 
iodinated radiotracer, with 5.8% of the total radio- 
activity. Peak C eluted in fractions 51-53 (81-83 
min time to elution) and contained the diiodinated 
radiotracer molecule with 13.6% of the total activ- 
ity. 
The specific activity of the compound isolated 
in fraction 39-41 (the monoiodinated species) was 
calculated using the method of Morris (1976) to 
be 1900 Ci /mmol  (following correction for count- 
ing efficiency and decay from the date of iodina- 
tion). This is in close agreement with the maxi- 
mum theoretical yield of 2180 Ci /mmol .  
Sera from rats and rabbits immunized with 
SAF-protein conjugates were screened for the abil- 
ity to bind the 125I tracer. Sera from two of three 
rats, and from six of ten rabbits, bound greater 
than 40% of the iodinated label at a 1 : 1000 serum 
dilution. Fig. 4 shows the complete titration curve 
of antisera from rabbit AF-60 at log dilutions 
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from 1 :10  to 1 :1000000.  Significant binding of 
the tracer molecule was detected at dilutions as 
high as 1 : 1 000 000. Similar dilutions of non-im- 
mune rabbit serum bound consistently less than 
2% of the tracer. A 1 : 100 000 dilution was chosen 
for the antibody specificity studies. 
Data presented in Table I clearly indicates a 
high degree of specificity toward ligands contain- 
ing a - N - C O - C H  2- at the 2 position of the 
fluorene ring. The antibody showed less affinity 
toward arylamines (2-aminofluorene, 2-aminoan- 
thracene, 1-aminoanthracene,  and 9-amino- 
fluorene) than for arylacetamides, and the 
specificity toward the ring structures alone was 
slightly less than for the corresponding arylamines. 
Surprisingly, the antibody specificity was higher 
toward 2-aminoanthracene and anthracene than 
for 2-aminofluorene and fluorene, respectively. 
Less related compounds had correspondingly 
higher crossreactivity values, (two and four mem- 
bered ring systems and ring systems with bulky 
side chains, e.g., 3-amino-l-ethylcarbazole). 
Fig. 5 shows the level of the anti-AAF antibody 
binding measured by microELISA when incubated 
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THE MASS OF THE COMPOUNDS SHOWN BELOW DISPLACED 50% OF THE 1251-RADIOLABEL (50000 CPM TOTAL) 
WHEN INCUBATED WITH A 1 : 100000 DILUTION OF ANTISERUM FROM RABBIT AF-60 (150) 
Following a 2 h equilibration period at room temperature, the bound and free counts were separated using dextran-coated charcoal, 
and the radioactivity was quantitated using a Hydrogamma-16 gamma counter. Cross-reactivity values were calculated based on a 
value of 1 for the non-iodinated carrier molecule (pHP-AAF). 
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Fig. 5. Competitive microELISA. Verification of the presence 
of anti-2-AAF immunoglobulins was performed by competi- 
tion experiments. Since the hapten (2-AAF) could not be 
adsorbed to the microtiter plates, carrier protein-SAF con- 
jugates were used. The highest titer rabbit (open rectangles) 
and rat antisera (shaded rectangles) were incubated for 1 h 
with the designated concentration (10 ng/well = 100 ng/ml in 
the incubation system) of 2-AAF. The antiserum-AAF mix- 
tures were then added to the microtiter plate and incubated for 
4 h at room temperature. The plates were washed three times 
with copious quantities of PT, and the appropriate second 
antibody conjugated to alkaline phosphatase was added (either 
sheep anti-rabbit IgG or goat anti-rat IgG). The absorbance at 
405 nm was measured, and the percent inhibition was calcu- 
lated from similar incubations containing no 2-AAF. Values 
expressed are the mean of two observations. 
in the presence of increasing concentrations of 
2-AAF. The inhibition of binding was clearly con- 
centration dependent and nearly 100% efficient at 
high 2-AAF concentrations (1 #g/wel l  for all rats 
tested). Rabbit AF-60 antiserum binding was 
inhibited 68% at the lowest concentration tested (1 
ng/well) and was over 90% inhibited at a con- 
centration of 10 ng/well.  Other rabbits in the 
series tested were not as sensitive to 2-AAF inhibi- 
tion, ranging from 6 to 38% inhibition at 1 ng/well.  
1ll 
Discussion 
The detection of antibodies directed against 
2-AAF is of critical importance in recent studies 
on the mucosal immune response to 2-AAF-car- 
rier protein conjugates conducted in our labora- 
tory (Keren et al., 1987). A rapid, sensitive, 
hapten-specific method which could be applied to 
a large number of specimens was required. The 
immunoglobulin binding method based on an 
125I-radiotracer was developed to meet this need. 
The 2-AAF binding assay described in this study 
was capable of detecting antibodies to 2-AAF at 
serum dilutions as high as 1 : 1 000 000. The pres- 
ence of anti-AAF immunoglobulin in antisera from 
immunized rats and rabbits testing positive by the 
immunoglobulin binding assay was confirmed by 
competitive microELISA. Increasing 2-AAF con- 
centrations caused dose-dependent inhibition of 
immunoglobulin binding to SAF-protein con- 
jugates. This inhibition was nearly 100% effective 
at a 2-AAF concentration of 1 /~g/well for both 
rat and rabbit antiserum. 
The 1251 radiotracer also allowed an examina- 
tion of the antibody specificity by performing 
cross-reactivity studies. These studies indicated 
that the polyclonal antibody response was directed 
primarily against the entire fluorenylacetamide 
group. Related compounds with ring substitutions 
or lacking the acetamide group were less able to 
compete with the tracer for the antibody binding 
sites. 
This method has proven very useful in the 
screening of both antiserum and intestinal secre- 
tions (Keren et al., 1987) from immunized rats 
and rabbits. Although not isotype specific, it pro- 
vides a simple, fast and sensitive screening assay 
for the detection of anti-AAF immunoglobulins in 
biological fluids. 
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